September 19/Web: The State of Patent Eligibility #MCLE

After the Supreme Court's decision in Prometheus and its vacatur and remand of the Myriad decision, the question of what constitutes patent eligible subject matter continues to pose a challenge to courts, the PTO and practitioners. This webinar will address the impact of the Prometheus decision on the eligibility question including what guidance it may provide with respect to the eligibility of gene patents, how the PTO is likely to react to the decision and the impact the decision will have on the medical field.
Title:
The State of Patent Eligibility
September 19, 2012
11:00 a.m. (Presumably Eastern - the website doesn't say)
Duration: 1 hour, 30 minutes
Webcast
Speakers:

• Eric E. Bensen is a coauthor of Milgrim on Trade Secrets (Matthew Bender), Milgrim on Licensing (Matthew Bender), and Patent Licensing Transactions, three leading intellectual property treatises, and Bensen & Myers on Litigation Management (LexisNexis), a groundbreaking new book that fully describes and illustrates a comprehensive, but easy to implement methodology for managing litigations that in-house counsel can use to ensure that their litigations are managed in a highly effective and cost efficient manner.  He advises clients on complex intellectual property issues.  Mr. Bensen has taught patent, copyright, and intellectual property licensing classes as a Visiting Assistant Professor of Law at Hofstra University School of Law.  Earlier in his career, Mr. Bensen was in practice for more than 12 years with Dewey Ballantine LLP and then Paul, Hastings, Janofsky & Walker LLP where he focused intellectual property litigation and licensing.  For more information, please visit http://www.ericbensen.com/.
• Eric P. Raciti is a Partner at Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. Eric focuses his practice on intellectual property counseling, particularly in the fields of alternative energy and medical devices. Among the diverse technologies that he has focused on are cardiac rhythm management, medical diagnostics, orthopedics, neuroscience, cardiology, neuroradiology, biofuels, and smart grid management. Mr. Raciti chairs Finnegan's alternative energy practice.
• Michael E. Singer is President and CEO of BrainScope Company, Inc. Michael  brings more than 20 years of executive leadership, healthcare and financial experience to BrainScope. He most recently was President, Revolution Health Investments, Revolution LLC, where he oversaw the health-related portfolio at Revolution. In particular he managed all external activities (partnerships, M&A, and investments) and assessed all new business opportunities at Revolution Health Group. Among his key achievements, he initiated, negotiated and completed several transactions that together created the Revolution Health Network and was instrumental in the merger of Revolution Health with Waterfront Media.

By:

• ManagingIP.com
• LexisNexis

More Information And Registration:
http://www.managingip.com/Web-Seminars.html